RxDoctor Payments Data

Sepehr Rejai, MD

Pain Medicine · Berkeley, CANPI 1760825806

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $41,943 of the $64,396 with a category attached, or 65.1%. SPR Therapeutics, Inc accounts for 81.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $26,980 and has fallen 85.6% since, to $3,896 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,396in general payments, 2019–2025

Across 154 payments — averaging $418.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$53K
  • Vertos Medical, Inc.$7K
  • Boston Scientific$5K
  • Abbott$114
  • Nevro Corp.$104
  • Saluda Medical Americas, Inc.$70
  • plus $17 from 1 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Consulting fees$41,94365%
  • Speaking & faculty fees$3,3005%
  • Travel & lodging$12,75820%
  • Food & beverage$6,37710%
  • Gifts$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,396 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$602,132
Medicare patients
619
Services billed
13,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl45$8,347
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen356$7,515
Gabapentin336$4,527
Buprenorphine Hcl44$2,715
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen94$2,697
Lidocaine19$2,428
Pregabalin99$2,395
Celecoxib75$2,010
Baclofen43$1,962
Tramadol Hcl100$1,329
Duloxetine Hcl56$1,293
Morphine Sulfate ErMorphine Sulfate24$1,256
Fentanyl12$941
Methadone Hcl44$940
Naloxone Hcl14$720

Paid to pharmacies, not to this prescriber.

Other pain medicine in Berkeley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →